The specific objectives of the Clinical Research Support Services (CRSS) Core are: ? To increase the quality and quantity of investigator-initiated clinical trials and facilitate the translational research efforts of the Cancer Center by providing assistance in protocol development, implementation and data capture. ? To increase the quality and quantity of grants and protocols in population research of the Cancer Center by providing assistance in study design, development of survey tools and recruitment. ? To provide a central core of personnel with expertise in all types of clinical trials management: regulatory;compliance, medical editing, and data management for investigator-initiated clinical intervention trials in cancer prevention, early detection and treatment and observational or epidemiology research relevant to cancer. ? To train and educate clinical research coordinators (data managers and nurses) in clinical intervention trials. ? To train and educate data managers and staff who conduct population-based research. ? To perform internal audits for data and safety monitoring. ? To increase the participation of subjects in clinical trials, with emphasis on diversity. ? -To provide a web-based protocol/data management system for all types of studies. ? To provide the infrastructure for the reporting requirements designated by the NCI. The Clinical Research Support Services Core serves four UCSF campuses: the in-patient and out-patient facilities at Mt. Zion and Parnassus, San Francisco General Hospital and San Francisco Veterans Administration Medical Center.
| Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131: |
| Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228 |
| Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408 |
| Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279 |
| Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380 |
| Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485 |
| An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575 |
| Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3: |
| Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607 |
| An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794 |
Showing the most recent 10 out of 192 publications
